12 January 2016
2 January 2016
African Treatment Advocates Call on ViiV Healthcare to Unlock Access to Dolutegravir …
Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to
20 November 2015
Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medici…
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients
23 October 2015
HIV
HIV : The MENA region still has one of the lowest HIV prevalence rates in the world (0.1%). However, MENA is increasingly becoming a region of concern regarding HIV and AIDS. Since 2001, new
14 October 2015
WHO Launches New HIV Treatment and Prevention Guidelines
The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis
1 October 2015
TREATMENT GUIDE
ITPC MENA has published a new comprehensive guide on the treatment of HIV infection in Arabic: ITPC MENA to publish in 2013 a comprehensive guide on the treatment of HIV infection in Arabic. The
1 October 2015
HCV
Hepatitis C: Hepatitis C virus (HCV), is a major health concern in MENA. A country like Egypt for example has the highest prevalence of HCV in the world. Pakistan has also a significant number
26 June 2015
Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatmen…
According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management
20 May 2015
Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Sufferin…
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis
10 July 2014